People with BMI 35+, type 2 diabetes, or urgent medical need for weight loss should discuss standard dosing protocols with their doctor first
Gastrointestinal Very common (10% or more): Nausea (up to 18%), diarrhea (up to 17%) Common (1% to 10%): Vomiting, constipation, dyspepsia, abdominal pain, eructation, flatulence, gastroesophageal reflux disease, abdominal distension Uncommon (0.1% to 1%): Cholelithiasis, acute pancreatitis, increased serum pancreatic amylase levels, increased serum lipase levels, acute gallbladder disease (including cholelithiasis, biliary colic and cholecystectomy) Postmarketing reports : Ileus In pooled placebo-controlled trials, treatment with this drug resulted in mean increases from baseline in serum pancreatic amylase levels of up to 38% and serum lipase levels of up to 42%
In a clinical trial of the Wegovy pill in people without diabetes, people taking a 25 mg dose lost about 6% of their body weight in three months
Id cycle off for 2 weeks and see an immediate bounce back
